Medical Research · PA
Transcelerate Biopharma Inc
Transcelerate Biopharma Inc reported paying Dalvir Gill, Former Ceo, $2,534,948 in total compensation (FY 2023).
That places Dalvir Gill at approximately the 100th percentile among 24 similarly sized medical research nonprofits (median $434,050).
$34,168,812Total revenue (FY 2023)
$2,534,948Total executive compensation
100thPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for Transcelerate Biopharma Inc — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
Compensation is normalized to PA cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| Max Planck Florida Corporation | FL | $33,505,675 | $497,742 |
| American Urological Association | MD | $35,355,221 | $599,411 |
| Nrg Oncology Foundation Inc | PA | $32,205,558 | $14,948 |
| Wills Eye Ophthalmology | PA | $31,970,742 | $256,175 |
| Bliss Cares Inc | FL | $36,602,971 | $178,847 |
| Greenwood Genetic Center Inc | SC | $31,727,683 | $437,761 |
| The Foundation Fighting Blindness Inc | MD | $36,615,169 | $530,319 |
| Delta Health Alliance Inc | MS | $37,178,547 | $530,838 |